# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 26263
- **Admission ID**: 105662
- **Row ID**: 14400
- **Profile Type**: FULL

## Demographics

- **Age**: 44
- **Sex**: M
- **Date of Birth**: 2079-09-08
- **Ethnicity**: WHITE
- **Marital Status**: MARRIED
- **Religion**: OTHER
- **Insurance**: Private
- **Admission Type**: EMERGENCY
- **Admission Date**: 2124-01-17 02:10:00
- **Discharge Date**: 2124-01-25 16:16:00

## Chief Complaint

LGIB

## Symptoms

- **rectal bleeding** | onset: a few hours prior to admission
- **darker stools**

## Medical History

Ehlers-Danlos syndrome type IV with bowel bleeds (mesenteric artery bleed), bilateral club feet with ankle surgeries, RP bleed in 2119 (no intervention), celiac artery aneurysm, GERD, HTN, left inguinal hernia repair, left eye blindness, bilateral carotid artery aneurysm

## Allergies

Mefoxin

## Current Medications

- **Ursodiol** | dosage: 300 mg
- **Protonix** | dosage: 40 mg

## Discharge Medications

- **Mesalamine enema** | dosage: 4 g/60 mL, 60 mL rectal daily | frequency: Daily
- **Ursodiol** | dosage: 300 mg | frequency: TID
- **Pantoprazole 40 mg Tablet, Delayed Release (E.C.)** | dosage: One (1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours) | frequency: every 24 hours

## Diagnoses

- **Lower gastrointestinal bleeding (LGIB)** | notes: Associated with Ehlers-Danlos syndrome type IV and history of bowel bleeds
- **Ehlers-Danlos syndrome type IV** | notes: Underlying condition contributing to bowel bleeds
- **lower GI bleed** | notes: Discharge diagnosis

## Treatment Options

### Colonoscopy

**Details**: Multiple clots found, no obvious source on first; ulceration near anastamotic site found on repeat

### Blood transfusion

**Details**: PRBCs given for dropping hematocrit

### Medication management

**Details**: Rowesa enemas, ursodiol, and protonix started

**Medications**:
- Mesalamine enema (4 g/60 mL, 60 mL rectal daily)
- Ursodiol (300 mg)
- Protonix (40 mg)

### Supportive care

**Details**: NPO, IV fluids, parenteral nutrition
